Literature DB >> 15390150

Assessment of lung perfusion impairment in patients with pulmonary artery-occlusive and chronic obstructive pulmonary diseases with noncontrast electrocardiogram-gated fast-spin-echo perfusion MR imaging.

Nobuhiko Ogasawara1, Kazuyoshi Suga, Mohammed Zaki, Munemasa Okada, Yasuhiko Kawakami, Naofumi Matsunaga.   

Abstract

PURPOSE: To evaluate the ability of noncontrast electrocardiogram (ECG)-gated fast-spin-echo (FSE) perfusion MR images for defining regional lung perfusion impairment, as compared with technetium (Tc)-99m macroaggregated albumin (MAA) single-photon emission computed tomography (SPECT) images.
MATERIALS AND METHODS: After acquisition of ECG-gated multiphase FSE MR images during cardiac cycles at selected lung levels in nine healthy volunteers, 11 patients with pulmonary artery-occlusive diseases, and 15 patients with chronic obstructive pulmonary diseases (COPD), the subtracted perfusion-weighted (PW) MR images were obtained from the two-phase images of the minimum lung signal intensity (SI) during systole and the maximum SI during diastole, and were compared with SPECT images.
RESULTS: ECG-gated PW images showed uniform but posture-dependent perfusion gradient in normal lungs and visualized the various sizes of perfusion defects in affected lungs. These defect sites were nearly consistent with those on SPECT images, with a significant correlation for the affected-to-unaffected perfusion contrast (r = 0.753; P < 0.0001). These MR images revealed that the pulmonary arterial blood flow in the affected areas of COPD was relatively preserved as compared with pulmonary artery-occlusive diseases, and also showed significant decrease in blood flow, even in the areas with homogeneous perfusion on SPECT images in patients with focal pulmonary emphysema.
CONCLUSION: This noninvasive MR technique allows qualitative and quantitative assessment of lung perfusion, and may better characterize regional perfusion impairment in pulmonary artery-occlusive diseases and COPD. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15390150     DOI: 10.1002/jmri.20150

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  (1)H-MR imaging of the lungs at 3.0 T.

Authors:  Sergei I Obruchkov; Michael D Noseworthy
Journal:  Quant Imaging Med Surg       Date:  2016-02

2.  Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging.

Authors:  Li Fan; Yi Xia; Yu Guan; Hong Yu; Tie-feng Zhang; Shi-yuan Liu; Bing Li
Journal:  Eur Radiol       Date:  2012-12-21       Impact factor: 5.315

Review 3.  Overview of MRI for pulmonary functional imaging.

Authors:  Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Hidekazu Hattori; Kazuhiro Murayama; Hiroshi Toyama
Journal:  Br J Radiol       Date:  2021-02-02       Impact factor: 3.629

Review 4.  State-of-the-art MR Imaging for Thoracic Diseases.

Authors:  Yumi Tanaka; Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Akiyoshi Iwase; Takashi Fukuba; Hidekazu Hattori; Kazuhiro Murayama; Takeshi Yoshikawa; Daisuke Takenaka; Hisanobu Koyama; Hiroshi Toyama
Journal:  Magn Reson Med Sci       Date:  2021-04-29       Impact factor: 2.760

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.